Get started
Author

Vincent Beuger

Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter
2003 · Siqin Wu, Cihan Cetinkaya, et al. · Oncogene · 327
Negative Regulation of the Mammalian UV Response by Myc through Association with Miz-1
2002 · Steffi Herold, Michael Wanzel, et al. · Molecular Cell · 315
PDF
The interaction between Myc and Miz1 is required to antagonize TGFβ-dependent autocrine signaling during lymphoma formation and maintenance
2010 · Jan van Riggelen, Judith Müller, et al. · Genes & Development · 114
PDF
Miz1 Is Required for Early Embryonic Development during Gastrulation
2003 · Sovana Adhikary, Karen Peukert, et al. · Molecular and Cellular Biology · 85
Lgr6 is a stem cell marker in mouse skin squamous cell carcinoma
2017 · Phillips Y Huang, Eve Kandyba, et al. · Nature Genetics · 61
Modeling Human Cytochrome P450 2D6 Metabolism and Drug-Drug Interaction by a Novel Panel of Knockout and Humanized Mouse Lines
2011 · Nico Scheer, Yury Kapelyukh, et al. · Molecular Pharmacology · 58
Polycomb group gene Ezh2 regulates mammary gland morphogenesis and maintains the luminal progenitor pool
2013 · Ewa Malgorzata Michalak, Karim Nacerddine, et al. · Stem Cells · 53
Short‐hairpin‐RNA‐mediated silencing of fucosyltransferase 8 in Chinese‐hamster ovary cells for the production of antibodies with enhanced antibody immune effector function
2008 · Vincent Beuger, Klaus‐Peter Künkele, et al. · Biotechnology and Applied Biochemistry · 31
Anticoagulation in Patients With Device‐Detected Atrial Fibrillation With and Without a Prior Stroke or Transient Ischemic Attack: The NOAH‐AFNET 6 Trial
2024 · Hans Christoph Diener, Nina Becher, et al. · Journal of the American Heart Association · 30
Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial
2024 · Gregory Y H Lip, Julius Nikorowitsch, et al. · European Heart Journal · 15
PDF
Kidney disease increases the risk of cardiovascular events in patients with device-detected atrial fibrillation: NOAH-AFNET 6
2026 · Andreas Goette, Marc D Lemoine, et al. · EP Europace · 4
Effects of anticoagulation in patients with device-detected atrial fibrillation and multiple stroke risk factors: a win ratio analysis of the NOAH-AFNET 6 trial
2025 · Nina Becher, Gina Köllner, et al. · European Heart Journal - Quality of Care and Clinical Outcomes · 4
PDF
Lb-525394-04 Distribution of Atrial Fibrillation Burden, Relation to Outcomes, and Effectiveness and Safety of Anticoagulation Based on Device Reports: the Noah-afnet 6 Trial
2026 · Ulrich Schotten, Ozan Özgül, et al. · Heart Rhythm
Works count: 14
Citation count: 1,097
H-index: 10
I10-index: 10
Year
Topic
Type